NYSE:CPHI China Pharma (CPHI) Stock Price, News & Analysis → (Free Workshop) Advanced “bug-out bag” hacks! (From Warrior Life) (Ad) Free CPHI Stock Alerts $0.26 -0.02 (-5.84%) (As of 06/14/2024 08:51 PM ET) Add Compare Share Share Today's Range$0.26▼$0.2750-Day Range$0.26▼$0.3852-Week Range$0.26▼$2.05Volume143,900 shsAverage Volume445,171 shsMarket Capitalization$4.09 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends Get China Pharma alerts: Email Address Ad Warrior Life(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” Most citizens don’t… but according to my friend (and best-selling survival author), Jeff, even the hardcore “preppers” who cherish their bug-out bags are doing it all wrong!All the details are right here… About China Pharma Stock (NYSE:CPHI)China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. In addition, the company provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. Further it offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Additionally, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It offers its products through distributors, its network of sales offices, and sales representatives. The company is based in Haikou, the People's Republic of China.Read More CPHI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CPHI Stock News HeadlinesJune 16 at 4:46 AM | americanbankingnews.comChina Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.comMay 28, 2024 | nasdaq.comTianjin Pharma Announces Upcoming Investor BriefingMay 12, 2024 | markets.businessinsider.comPhotocure : Asieris' NDA For Cevira Accepted By NMPA For Regulatory Review In ChinaMay 5, 2024 | morningstar.comChina Pharma Holding Inc CPHIMarch 22, 2024 | morningstar.comChina Pharma Holding IncMarch 14, 2024 | msn.comChina Healthcare Stocks Rally on Hopes for Govt SupportMarch 14, 2024 | msn.comChina Healthcare Stocks Rally on Hopes for Govt SupportMarch 11, 2024 | tmcnet.comRising Demand for Secure Packaging Solutions and Enhanced Aesthetic Appeal Propels Market to US$ 432.1M by 2034 | Future Market Insights, Inc.March 6, 2024 | finance.yahoo.comChina Pharma Holdings, Inc. (CPHI)February 27, 2024 | benzinga.comChina Pharma Holding Stock (AMEX:CPHI), Insider Trading ActivityFebruary 27, 2024 | benzinga.comChina Pharma Holding Stock (AMEX:CPHI), Guidance and ForecastFebruary 24, 2024 | finanznachrichten.deChina Pharma Holdings, Inc.: China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock SplitFebruary 23, 2024 | prnewswire.comChina Pharma Holdings Inc. Announces 1-for-5 Reverse Stock SplitFebruary 9, 2024 | markets.businessinsider.comChina Pharma Holdings Issues 15M Unregistered SharesFebruary 9, 2024 | msn.comChina Pharma Holdings Acquires Psoriasis Patent and Profit DealFebruary 6, 2024 | msn.comScoop: China panel plans biotech field hearingFebruary 6, 2024 | axios.comExclusive: China panel eyes biotech field hearingJanuary 23, 2024 | investing.comChina SXT Pharmaceuticals Inc (SXTC)January 23, 2024 | wsj.comChina Pharma Holdings Inc.November 29, 2023 | msn.comChina’s new cancer drug is approved in the US but will cost 30 times moreNovember 29, 2023 | finance.yahoo.comChina Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic DeviceNovember 29, 2023 | finance.yahoo.comChina Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic DeviceNovember 21, 2023 | msn.comAnother top executive is being investigated by China’s corruption watchdogNovember 8, 2023 | markets.businessinsider.comCASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY CHINA NMPANovember 7, 2023 | markets.businessinsider.comKexing Biopharm Attended CPHI Worldwide 2023See More Headlines Receive CPHI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for China Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2024Today6/16/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNYSE:CPHI CUSIPN/A CIK1106644 Webwww.chinapharmaholdings.com Phone8689866811730Fax86-898-6681-9024Employees231Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,080,000.00 Net Margins-55.42% Pretax Margin-55.42% Return on Equity-54.31% Return on Assets-22.34% Debt Debt-to-Equity Ratio0.17 Current Ratio0.89 Quick Ratio0.25 Sales & Book Value Annual Sales$7.01 million Price / Sales0.58 Cash FlowN/A Price / Cash FlowN/A Book Value$0.70 per share Price / Book0.37Miscellaneous Outstanding Shares15,870,000Free Float8,570,000Market Cap$4.09 million OptionableNot Optionable Beta0.85 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMs. Zhilin Li (Age 71)President, CEO, Chairman & Interim CFO Comp: $241.6kMs. Huang Na C.F.A.BOD Secretary & IR ManagerKey CompetitorsPurple BiotechNASDAQ:PPBTGalectoNASDAQ:GLTOEdesa BiotechNASDAQ:EDSAMonopar TherapeuticsNASDAQ:MNPRFlora GrowthNASDAQ:FLGCView All Competitors CPHI Stock Analysis - Frequently Asked Questions How have CPHI shares performed in 2024? China Pharma's stock was trading at $0.6050 at the start of the year. Since then, CPHI stock has decreased by 57.4% and is now trading at $0.2579. View the best growth stocks for 2024 here. How were China Pharma's earnings last quarter? China Pharma Holdings, Inc. (NYSE:CPHI) posted its quarterly earnings data on Wednesday, May, 15th. The company reported ($0.07) EPS for the quarter. The business had revenue of $1.37 million for the quarter. China Pharma had a negative net margin of 55.42% and a negative trailing twelve-month return on equity of 54.31%. When did China Pharma's stock split? Shares of China Pharma reverse split before market open on Wednesday, March 6th 2024. The 1-5 reverse split was announced on Wednesday, March 6th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, March 6th 2024. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split. What other stocks do shareholders of China Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other China Pharma investors own include iShares Silver Trust (SLV), Check-Cap (CHEK), ContraFect (CFRX), Clear Channel Outdoor (CCO), Boxlight (BOXL), Bionano Genomics (BNGO), Athersys (ATHX), Assertio (ASRT), AMC Entertainment (AMC). How do I buy shares of China Pharma? Shares of CPHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:CPHI) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored(Free Workshop) Advanced “bug-out bag” hacks!“Do you have a ‘bug-out bag’ (survival kit) ready to grab-and-go when a disaster or other crisis strikes?” ...Warrior Life | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China Pharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.